Regional Analysis

Global Sevoflurane Market – Regional Analysis

On the basis of region, the global sevoflurane market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global sevoflurane market over the forecast period, owing to increasing standards of surgical care in the U.S. For instance, in July 2019, at the ACS Quality and Safety Conference, the American College of Surgeons (ACS) announced the introduction of its new Geriatric Surgery Verification (GSV) Program. This new surgical quality improvement initiative incorporates 30 new surgical criteria aimed at systematically improving surgical treatment and outcomes in the elderly.

Moreover, due to increasing number of surgeries, Asia Pacific is expected to witness a significant growth in the global sevoflurane market over the forecast period. For instance, according to the World Journal of Surgery, 2021, annually, 3646 procedures were performed to address the surgical needs of the Indian population, compared to 5000 surgeries per 100,000 people globally. Caesarean section, cataract surgery, fracture and hernia surgeries were the most common surgical procedures.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa